nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Teniposide—lymphatic system cancer	0.258	0.367	CbGbCtD
Argatroban—CYP3A5—Vincristine—lymphatic system cancer	0.124	0.176	CbGbCtD
Argatroban—CYP3A4—Cytarabine—lymphatic system cancer	0.102	0.145	CbGbCtD
Argatroban—CYP3A4—Teniposide—lymphatic system cancer	0.1	0.143	CbGbCtD
Argatroban—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0703	0.1	CbGbCtD
Argatroban—CYP3A4—Vincristine—lymphatic system cancer	0.0484	0.0688	CbGbCtD
Argatroban—Thrombosis—Mechlorethamine—lymphatic system cancer	0.00941	0.0317	CcSEcCtD
Argatroban—Digestion impaired—Fludarabine—lymphatic system cancer	0.00646	0.0217	CcSEcCtD
Argatroban—Haemorrhage intracranial—Mitoxantrone—lymphatic system cancer	0.00626	0.0211	CcSEcCtD
Argatroban—Haemoptysis—Fludarabine—lymphatic system cancer	0.00583	0.0196	CcSEcCtD
Argatroban—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.00559	0.0188	CcSEcCtD
Argatroban—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.00506	0.017	CcSEcCtD
Argatroban—Arterial thrombosis—Methotrexate—lymphatic system cancer	0.00475	0.016	CcSEcCtD
Argatroban—Respiratory failure—Fludarabine—lymphatic system cancer	0.0044	0.0148	CcSEcCtD
Argatroban—Sepsis—Teniposide—lymphatic system cancer	0.00426	0.0143	CcSEcCtD
Argatroban—Thrombosis—Carmustine—lymphatic system cancer	0.0039	0.0131	CcSEcCtD
Argatroban—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00336	0.0113	CcSEcCtD
Argatroban—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00335	0.0113	CcSEcCtD
Argatroban—Cardiac failure—Fludarabine—lymphatic system cancer	0.00321	0.0108	CcSEcCtD
Argatroban—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.0032	0.0108	CcSEcCtD
Argatroban—Myocardial ischaemia—Mitoxantrone—lymphatic system cancer	0.0032	0.0108	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00313	0.0105	CcSEcCtD
Argatroban—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00276	0.0093	CcSEcCtD
Argatroban—Respiratory failure—Vincristine—lymphatic system cancer	0.00269	0.00904	CcSEcCtD
Argatroban—Angina pectoris—Fludarabine—lymphatic system cancer	0.00264	0.00888	CcSEcCtD
Argatroban—Haemoglobin—Teniposide—lymphatic system cancer	0.00248	0.00834	CcSEcCtD
Argatroban—Haemorrhage—Teniposide—lymphatic system cancer	0.00247	0.0083	CcSEcCtD
Argatroban—Pneumonia—Fludarabine—lymphatic system cancer	0.00243	0.00818	CcSEcCtD
Argatroban—Sepsis—Carmustine—lymphatic system cancer	0.0024	0.00807	CcSEcCtD
Argatroban—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00238	0.00801	CcSEcCtD
Argatroban—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00237	0.00797	CcSEcCtD
Argatroban—Infection—Mechlorethamine—lymphatic system cancer	0.00236	0.00795	CcSEcCtD
Argatroban—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00235	0.0079	CcSEcCtD
Argatroban—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00234	0.00789	CcSEcCtD
Argatroban—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00232	0.0078	CcSEcCtD
Argatroban—Haematuria—Fludarabine—lymphatic system cancer	0.0023	0.00775	CcSEcCtD
Argatroban—Sepsis—Mitoxantrone—lymphatic system cancer	0.00223	0.0075	CcSEcCtD
Argatroban—Haemoglobin—Fludarabine—lymphatic system cancer	0.00218	0.00733	CcSEcCtD
Argatroban—Haemorrhage—Fludarabine—lymphatic system cancer	0.00217	0.0073	CcSEcCtD
Argatroban—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00202	0.0068	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00201	0.00675	CcSEcCtD
Argatroban—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00191	0.00643	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00186	0.00628	CcSEcCtD
Argatroban—Haematemesis—Methotrexate—lymphatic system cancer	0.00184	0.0062	CcSEcCtD
Argatroban—Chest pain—Teniposide—lymphatic system cancer	0.00183	0.00615	CcSEcCtD
Argatroban—Cardiac arrest—Vincristine—lymphatic system cancer	0.00182	0.00613	CcSEcCtD
Argatroban—Pneumonia—Bleomycin—lymphatic system cancer	0.00178	0.00599	CcSEcCtD
Argatroban—Confusional state—Teniposide—lymphatic system cancer	0.00177	0.00595	CcSEcCtD
Argatroban—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00175	0.00589	CcSEcCtD
Argatroban—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00175	0.00588	CcSEcCtD
Argatroban—Infection—Teniposide—lymphatic system cancer	0.00174	0.00586	CcSEcCtD
Argatroban—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00174	0.00584	CcSEcCtD
Argatroban—Tachycardia—Teniposide—lymphatic system cancer	0.00171	0.00576	CcSEcCtD
Argatroban—Haematuria—Bleomycin—lymphatic system cancer	0.00169	0.00568	CcSEcCtD
Argatroban—Pleural effusion—Methotrexate—lymphatic system cancer	0.00167	0.00562	CcSEcCtD
Argatroban—Cough—Fludarabine—lymphatic system cancer	0.00165	0.00554	CcSEcCtD
Argatroban—Hypotension—Teniposide—lymphatic system cancer	0.00164	0.00551	CcSEcCtD
Argatroban—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00163	0.00547	CcSEcCtD
Argatroban—Haemoglobin—Bleomycin—lymphatic system cancer	0.0016	0.00538	CcSEcCtD
Argatroban—Haemorrhage—Bleomycin—lymphatic system cancer	0.00159	0.00535	CcSEcCtD
Argatroban—Dyspnoea—Teniposide—lymphatic system cancer	0.00156	0.00526	CcSEcCtD
Argatroban—Pneumonia—Carmustine—lymphatic system cancer	0.00155	0.00523	CcSEcCtD
Argatroban—Confusional state—Fludarabine—lymphatic system cancer	0.00155	0.00523	CcSEcCtD
Argatroban—Infection—Fludarabine—lymphatic system cancer	0.00153	0.00515	CcSEcCtD
Argatroban—Vomiting—Mechlorethamine—lymphatic system cancer	0.00151	0.00509	CcSEcCtD
Argatroban—Apnoea—Methotrexate—lymphatic system cancer	0.00151	0.00508	CcSEcCtD
Argatroban—Urinary tract infection—Carmustine—lymphatic system cancer	0.0015	0.00506	CcSEcCtD
Argatroban—Rash—Mechlorethamine—lymphatic system cancer	0.0015	0.00504	CcSEcCtD
Argatroban—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0015	0.00504	CcSEcCtD
Argatroban—Pneumonia—Vincristine—lymphatic system cancer	0.00148	0.00499	CcSEcCtD
Argatroban—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00145	0.0049	CcSEcCtD
Argatroban—Myocardial infarction—Vincristine—lymphatic system cancer	0.00145	0.00487	CcSEcCtD
Argatroban—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00145	0.00486	CcSEcCtD
Argatroban—Feeling abnormal—Teniposide—lymphatic system cancer	0.00144	0.00486	CcSEcCtD
Argatroban—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00143	0.00482	CcSEcCtD
Argatroban—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00142	0.00477	CcSEcCtD
Argatroban—Nausea—Mechlorethamine—lymphatic system cancer	0.00141	0.00475	CcSEcCtD
Argatroban—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00141	0.00474	CcSEcCtD
Argatroban—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.0014	0.0047	CcSEcCtD
Argatroban—Haemoglobin—Carmustine—lymphatic system cancer	0.00139	0.00469	CcSEcCtD
Argatroban—Haemorrhage—Carmustine—lymphatic system cancer	0.00139	0.00467	CcSEcCtD
Argatroban—Abdominal pain—Teniposide—lymphatic system cancer	0.00139	0.00466	CcSEcCtD
Argatroban—Body temperature increased—Teniposide—lymphatic system cancer	0.00139	0.00466	CcSEcCtD
Argatroban—Dyspnoea—Fludarabine—lymphatic system cancer	0.00137	0.00462	CcSEcCtD
Argatroban—Haematuria—Mitoxantrone—lymphatic system cancer	0.00137	0.00461	CcSEcCtD
Argatroban—Dyspepsia—Fludarabine—lymphatic system cancer	0.00136	0.00456	CcSEcCtD
Argatroban—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00133	0.00448	CcSEcCtD
Argatroban—Pain—Fludarabine—lymphatic system cancer	0.00132	0.00443	CcSEcCtD
Argatroban—Constipation—Fludarabine—lymphatic system cancer	0.00132	0.00443	CcSEcCtD
Argatroban—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00131	0.00442	CcSEcCtD
Argatroban—Respiratory failure—Methotrexate—lymphatic system cancer	0.0013	0.00439	CcSEcCtD
Argatroban—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.0013	0.00436	CcSEcCtD
Argatroban—Hypersensitivity—Teniposide—lymphatic system cancer	0.00129	0.00435	CcSEcCtD
Argatroban—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00129	0.00434	CcSEcCtD
Argatroban—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00128	0.00431	CcSEcCtD
Argatroban—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00127	0.00427	CcSEcCtD
Argatroban—Body temperature increased—Fludarabine—lymphatic system cancer	0.00122	0.0041	CcSEcCtD
Argatroban—Cough—Bleomycin—lymphatic system cancer	0.00121	0.00406	CcSEcCtD
Argatroban—Angiopathy—Vincristine—lymphatic system cancer	0.0012	0.00404	CcSEcCtD
Argatroban—Diarrhoea—Teniposide—lymphatic system cancer	0.0012	0.00404	CcSEcCtD
Argatroban—Chest pain—Bleomycin—lymphatic system cancer	0.00118	0.00397	CcSEcCtD
Argatroban—Back pain—Carmustine—lymphatic system cancer	0.00117	0.00393	CcSEcCtD
Argatroban—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00114	0.00383	CcSEcCtD
Argatroban—Confusional state—Bleomycin—lymphatic system cancer	0.00114	0.00383	CcSEcCtD
Argatroban—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00113	0.00382	CcSEcCtD
Argatroban—Infection—Bleomycin—lymphatic system cancer	0.00112	0.00378	CcSEcCtD
Argatroban—Back pain—Vincristine—lymphatic system cancer	0.00112	0.00375	CcSEcCtD
Argatroban—Vomiting—Teniposide—lymphatic system cancer	0.00111	0.00375	CcSEcCtD
Argatroban—Sepsis—Methotrexate—lymphatic system cancer	0.00111	0.00374	CcSEcCtD
Argatroban—Rash—Teniposide—lymphatic system cancer	0.0011	0.00372	CcSEcCtD
Argatroban—Dermatitis—Teniposide—lymphatic system cancer	0.0011	0.00372	CcSEcCtD
Argatroban—Headache—Teniposide—lymphatic system cancer	0.0011	0.0037	CcSEcCtD
Argatroban—Back pain—Mitoxantrone—lymphatic system cancer	0.00109	0.00366	CcSEcCtD
Argatroban—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00107	0.00361	CcSEcCtD
Argatroban—Hypotension—Bleomycin—lymphatic system cancer	0.00106	0.00355	CcSEcCtD
Argatroban—Diarrhoea—Fludarabine—lymphatic system cancer	0.00105	0.00355	CcSEcCtD
Argatroban—Nausea—Teniposide—lymphatic system cancer	0.00104	0.0035	CcSEcCtD
Argatroban—Chest pain—Carmustine—lymphatic system cancer	0.00103	0.00346	CcSEcCtD
Argatroban—Dyspnoea—Bleomycin—lymphatic system cancer	0.00101	0.00339	CcSEcCtD
Argatroban—Renal failure acute—Methotrexate—lymphatic system cancer	0.00101	0.00339	CcSEcCtD
Argatroban—Confusional state—Carmustine—lymphatic system cancer	0.000994	0.00335	CcSEcCtD
Argatroban—Cough—Mitoxantrone—lymphatic system cancer	0.00098	0.0033	CcSEcCtD
Argatroban—Infection—Carmustine—lymphatic system cancer	0.000979	0.0033	CcSEcCtD
Argatroban—Vomiting—Fludarabine—lymphatic system cancer	0.000979	0.0033	CcSEcCtD
Argatroban—Rash—Fludarabine—lymphatic system cancer	0.000971	0.00327	CcSEcCtD
Argatroban—Dermatitis—Fludarabine—lymphatic system cancer	0.00097	0.00327	CcSEcCtD
Argatroban—Pain—Bleomycin—lymphatic system cancer	0.000966	0.00325	CcSEcCtD
Argatroban—Headache—Fludarabine—lymphatic system cancer	0.000965	0.00325	CcSEcCtD
Argatroban—Tachycardia—Carmustine—lymphatic system cancer	0.000962	0.00324	CcSEcCtD
Argatroban—Chest pain—Mitoxantrone—lymphatic system cancer	0.000956	0.00322	CcSEcCtD
Argatroban—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000948	0.00319	CcSEcCtD
Argatroban—Infection—Vincristine—lymphatic system cancer	0.000935	0.00315	CcSEcCtD
Argatroban—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000931	0.00313	CcSEcCtD
Argatroban—Confusional state—Mitoxantrone—lymphatic system cancer	0.000924	0.00311	CcSEcCtD
Argatroban—Hypotension—Carmustine—lymphatic system cancer	0.000921	0.0031	CcSEcCtD
Argatroban—Nausea—Fludarabine—lymphatic system cancer	0.000915	0.00308	CcSEcCtD
Argatroban—Infection—Mitoxantrone—lymphatic system cancer	0.00091	0.00306	CcSEcCtD
Argatroban—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000894	0.00301	CcSEcCtD
Argatroban—Body temperature increased—Bleomycin—lymphatic system cancer	0.000893	0.003	CcSEcCtD
Argatroban—Hypotension—Vincristine—lymphatic system cancer	0.000879	0.00296	CcSEcCtD
Argatroban—Dyspnoea—Carmustine—lymphatic system cancer	0.000879	0.00296	CcSEcCtD
Argatroban—Hypotension—Mitoxantrone—lymphatic system cancer	0.000856	0.00288	CcSEcCtD
Argatroban—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000851	0.00286	CcSEcCtD
Argatroban—Pain—Carmustine—lymphatic system cancer	0.000843	0.00284	CcSEcCtD
Argatroban—Constipation—Carmustine—lymphatic system cancer	0.000843	0.00284	CcSEcCtD
Argatroban—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000832	0.0028	CcSEcCtD
Argatroban—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000817	0.00275	CcSEcCtD
Argatroban—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000812	0.00273	CcSEcCtD
Argatroban—Feeling abnormal—Carmustine—lymphatic system cancer	0.000812	0.00273	CcSEcCtD
Argatroban—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000807	0.00272	CcSEcCtD
Argatroban—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000806	0.00271	CcSEcCtD
Argatroban—Pain—Vincristine—lymphatic system cancer	0.000805	0.00271	CcSEcCtD
Argatroban—Constipation—Vincristine—lymphatic system cancer	0.000805	0.00271	CcSEcCtD
Argatroban—Pain—Mitoxantrone—lymphatic system cancer	0.000784	0.00264	CcSEcCtD
Argatroban—Constipation—Mitoxantrone—lymphatic system cancer	0.000784	0.00264	CcSEcCtD
Argatroban—Abdominal pain—Carmustine—lymphatic system cancer	0.000779	0.00262	CcSEcCtD
Argatroban—Body temperature increased—Carmustine—lymphatic system cancer	0.000779	0.00262	CcSEcCtD
Argatroban—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000769	0.00259	CcSEcCtD
Argatroban—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000755	0.00254	CcSEcCtD
Argatroban—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000749	0.00252	CcSEcCtD
Argatroban—Body temperature increased—Vincristine—lymphatic system cancer	0.000744	0.0025	CcSEcCtD
Argatroban—Abdominal pain—Vincristine—lymphatic system cancer	0.000744	0.0025	CcSEcCtD
Argatroban—Hypersensitivity—Carmustine—lymphatic system cancer	0.000726	0.00244	CcSEcCtD
Argatroban—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000724	0.00244	CcSEcCtD
Argatroban—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000724	0.00244	CcSEcCtD
Argatroban—Pneumonia—Methotrexate—lymphatic system cancer	0.00072	0.00242	CcSEcCtD
Argatroban—Vomiting—Bleomycin—lymphatic system cancer	0.000718	0.00242	CcSEcCtD
Argatroban—Rash—Bleomycin—lymphatic system cancer	0.000712	0.0024	CcSEcCtD
Argatroban—Dermatitis—Bleomycin—lymphatic system cancer	0.000711	0.00239	CcSEcCtD
Argatroban—Hypersensitivity—Vincristine—lymphatic system cancer	0.000693	0.00233	CcSEcCtD
Argatroban—Haematuria—Methotrexate—lymphatic system cancer	0.000683	0.0023	CcSEcCtD
Argatroban—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000675	0.00227	CcSEcCtD
Argatroban—Diarrhoea—Carmustine—lymphatic system cancer	0.000674	0.00227	CcSEcCtD
Argatroban—Nausea—Bleomycin—lymphatic system cancer	0.000671	0.00226	CcSEcCtD
Argatroban—Dizziness—Carmustine—lymphatic system cancer	0.000652	0.00219	CcSEcCtD
Argatroban—Haemoglobin—Methotrexate—lymphatic system cancer	0.000646	0.00217	CcSEcCtD
Argatroban—Diarrhoea—Vincristine—lymphatic system cancer	0.000644	0.00217	CcSEcCtD
Argatroban—Haemorrhage—Methotrexate—lymphatic system cancer	0.000643	0.00216	CcSEcCtD
Argatroban—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000627	0.00211	CcSEcCtD
Argatroban—Vomiting—Carmustine—lymphatic system cancer	0.000627	0.00211	CcSEcCtD
Argatroban—Dizziness—Vincristine—lymphatic system cancer	0.000622	0.00209	CcSEcCtD
Argatroban—Rash—Carmustine—lymphatic system cancer	0.000621	0.00209	CcSEcCtD
Argatroban—Dermatitis—Carmustine—lymphatic system cancer	0.000621	0.00209	CcSEcCtD
Argatroban—Headache—Carmustine—lymphatic system cancer	0.000618	0.00208	CcSEcCtD
Argatroban—Vomiting—Vincristine—lymphatic system cancer	0.000598	0.00201	CcSEcCtD
Argatroban—Rash—Vincristine—lymphatic system cancer	0.000593	0.002	CcSEcCtD
Argatroban—Dermatitis—Vincristine—lymphatic system cancer	0.000593	0.002	CcSEcCtD
Argatroban—Headache—Vincristine—lymphatic system cancer	0.000589	0.00198	CcSEcCtD
Argatroban—Nausea—Carmustine—lymphatic system cancer	0.000585	0.00197	CcSEcCtD
Argatroban—Angiopathy—Methotrexate—lymphatic system cancer	0.000583	0.00196	CcSEcCtD
Argatroban—Vomiting—Mitoxantrone—lymphatic system cancer	0.000583	0.00196	CcSEcCtD
Argatroban—Rash—Mitoxantrone—lymphatic system cancer	0.000578	0.00194	CcSEcCtD
Argatroban—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000577	0.00194	CcSEcCtD
Argatroban—Headache—Mitoxantrone—lymphatic system cancer	0.000574	0.00193	CcSEcCtD
Argatroban—Nausea—Vincristine—lymphatic system cancer	0.000559	0.00188	CcSEcCtD
Argatroban—Nausea—Mitoxantrone—lymphatic system cancer	0.000544	0.00183	CcSEcCtD
Argatroban—Back pain—Methotrexate—lymphatic system cancer	0.000541	0.00182	CcSEcCtD
Argatroban—Cough—Methotrexate—lymphatic system cancer	0.000488	0.00164	CcSEcCtD
Argatroban—Chest pain—Methotrexate—lymphatic system cancer	0.000476	0.0016	CcSEcCtD
Argatroban—Confusional state—Methotrexate—lymphatic system cancer	0.00046	0.00155	CcSEcCtD
Argatroban—Infection—Methotrexate—lymphatic system cancer	0.000454	0.00153	CcSEcCtD
Argatroban—Hypotension—Methotrexate—lymphatic system cancer	0.000427	0.00144	CcSEcCtD
Argatroban—Dyspnoea—Methotrexate—lymphatic system cancer	0.000407	0.00137	CcSEcCtD
Argatroban—Dyspepsia—Methotrexate—lymphatic system cancer	0.000402	0.00135	CcSEcCtD
Argatroban—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000394	0.00133	CcSEcCtD
Argatroban—Pain—Methotrexate—lymphatic system cancer	0.00039	0.00131	CcSEcCtD
Argatroban—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000376	0.00127	CcSEcCtD
Argatroban—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000373	0.00126	CcSEcCtD
Argatroban—Abdominal pain—Methotrexate—lymphatic system cancer	0.000361	0.00121	CcSEcCtD
Argatroban—Body temperature increased—Methotrexate—lymphatic system cancer	0.000361	0.00121	CcSEcCtD
Argatroban—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000336	0.00113	CcSEcCtD
Argatroban—Diarrhoea—Methotrexate—lymphatic system cancer	0.000312	0.00105	CcSEcCtD
Argatroban—Dizziness—Methotrexate—lymphatic system cancer	0.000302	0.00102	CcSEcCtD
Argatroban—Vomiting—Methotrexate—lymphatic system cancer	0.00029	0.000977	CcSEcCtD
Argatroban—Rash—Methotrexate—lymphatic system cancer	0.000288	0.000969	CcSEcCtD
Argatroban—Dermatitis—Methotrexate—lymphatic system cancer	0.000288	0.000968	CcSEcCtD
Argatroban—Headache—Methotrexate—lymphatic system cancer	0.000286	0.000963	CcSEcCtD
Argatroban—Nausea—Methotrexate—lymphatic system cancer	0.000271	0.000913	CcSEcCtD
